References
1. Vece TJ, Young LR. 2016. Update on diffuse lung disease in children.
Chest. 149(3):836-845.
2. Nogee LM, de Mello DE, Dehner LP, Colten HR. 1993. Brief report:
Deficiency of pulmonary surfactant protein b in congenital alveolar
proteinosis. N Engl J Med. 328(6):406-410.
3. Nogee LM, Dunbar AE, 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA.
2001. A mutation in the surfactant protein c gene associated with
familial interstitial lung disease. N Engl J Med. 344(8):573-579.
4. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. 2005. Abca3
mutations associated with pediatric interstitial lung disease. Am J
Respir Crit Care Med. 172(8):1026-1031.
5. Deterding RR, Pye C, Fan LL, Langston C. 2005. Persistent tachypnea
of infancy is associated with neuroendocrine cell hyperplasia. Pediatr
Pulmonol. 40(2):157-165.
6. Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody
AS, Nogee LM, Trapnell BC, Langston C et al. 2007. Diffuse lung disease
in young children: Application of a novel classification scheme. Am J
Respir Crit Care Med. 176(11):1120-1128.
7. Fan LL, Dishop MK, Galambos C, Askin FB, White FV, Langston C,
Liptzin DR, Kroehl ME, Deutsch GH, Young LR et al. 2015. Diffuse lung
disease in biopsied children 2 to 18 years of age. Application of the
child classification scheme. Ann Am Thorac Soc. 12(10):1498-1505.
8. Kurland G, Deterding RR, Hagood JS, Young LR, Brody AS, Castile RG,
Dell S, Fan LL, Hamvas A, Hilman BC et al. 2013. An official american
thoracic society clinical practice guideline: Classification,
evaluation, and management of childhood interstitial lung disease in
infancy. Am J Respir Crit Care Med. 188(3):376-394.
9. Popler J, Lesnick B, Dishop MK, Deterding RR. 2012. New coding in the
international classification of diseases, ninth revision, for children’s
interstitial lung disease. Chest. 142(3):774-780.
10. Icd-10-cm coding for interstitial lung diseases. 2015. In: Plummer
AL, editor. Coding & Billing Quarterly: American Thoracic Society.
11. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. 2009.
Research electronic data capture (redcap)–a metadata-driven
methodology and workflow process for providing translational research
informatics support. J Biomed Inform. 42(2):377-381.
12. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L,
McLeod L, Delacqua G, Delacqua F, Kirby J et al. 2019. The redcap
consortium: Building an international community of software platform
partners. J Biomed Inform. 95:103208.
13. Clement A, Force ERST. 2004. Task force on chronic interstitial lung
disease in immunocompetent children. Eur Respir J. 24(4):686-697.
14. Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, Kiper N,
Emiralioglu N, Snijders D, Goldbeck L et al. 2018. International
management platform for children’s interstitial lung disease (child-eu).
Thorax. 73(3):231-239.
15. Soares JJ, Deutsch GH, Moore PE, Fazili MF, Austin ED, Brown RF,
Sokolow AG, Hilmes MA, Young LR. 2013. Childhood interstitial lung
diseases: An 18-year retrospective analysis. Pediatrics. 132(4):684-691.
16. Temple SEL, Ho G, Bennetts B, Boggs K, Vidic N, Mowat D,
Christodoulou J, Schultz A, Gayagay T, Roscioli T et al. 2022. The role
of exome sequencing in childhood interstitial or diffuse lung disease.
Orphanet J Rare Dis. 17(1):350.
17. Saddi V, Beggs S, Bennetts B, Harrison J, Hime N, Kapur N, Lipsett
J, Nogee LM, Phu A, Suresh S et al. 2017. Childhood interstitial lung
diseases in immunocompetent children in australia and new zealand: A
decade’s experience. Orphanet J Rare Dis. 12(1):133.
18. Terwiel M, Borie R, Crestani B, Galvin L, Bonella F, Fabre A,
Froidure A, Griese M, Grutters JC, Johannson K et al. 2022. Genetic
testing in interstitial lung disease: An international survey.
Respirology. 27(9):747-757.
19. Seidl E, Schwerk N, Carlens J, Wetzke M, Cunningham S, Emiralioglu
N, Kiper N, Lange J, Krenke K, Ullmann N et al. 2022. Healthcare
resource utilisation and medical costs for children with interstitial
lung diseases (child) in europe. Thorax. 77(8):781-789.